Israel takes a risk on tomorrow’s epic drugs
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
Israel’s RDD Pharma is developing novel therapeutics for gastro and anorectal disorders people are embarrassed to discuss with their doctors.